CClinicalTrials.gg
CompletedNCT06176521Updated Aug 6, 2025

Evaluation of the Results of Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh in the Surgical Treatment of Pelvic Organ Prolapse

An interventional study of Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh in Pelvic Organ Prolapse, sponsored by Gaziosmanpasa Research and Education Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Gaziosmanpasa Research and Education Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Evaluation of the anatomical and functional results of laparoscopic sacrohysteropexy and sacrocolpopexy surgeries performed without using mesh in the surgical treatment of pelvic organ prolapse

02

Conditions studied

  • Pelvic Organ Prolapse

Browse trials for

Keywords

  • sacrocolpopexy
  • sacrohysteropexy
  • pelvic organ prolapse
03

In context

Pelvic Organ Prolapse

509 studies on the registry are indexed under Pelvic Organ Prolapse; 81 are open to participants now.

This study's enrollment of 35 is below the median of 80 across 330 interventional studies indexed under Pelvic Organ Prolapse.

Browse Pelvic Organ Prolapse studies →

Lead sponsor

Gaziosmanpasa Research and Education Hospital is the lead sponsor of 122 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. being 18 years old or older
  2. needing an operation for symptomatic pelvic organ prolapse -

Exclusion criteria

Exclusion Criteria:

  1. past history of chemotherapy or radiotherapy
  2. past history of pelvic organ prolapse surgery
  3. if there is a contraindication of laparoscopy -
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Other
    Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh

    Procedure: Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh

Interventions

  • ProcedureLaparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh

    Comparison of pre and postoperative POP-Q values of the patients undergone Laparoscopic Sacrohysteropexy and Sacrocolpopexy SurgeriesWithout Using Mesh Comparison of pre and postoperative PISQ-12 scores of the patients undergone Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Without Using Mesh

    Also known as: Comparison of pre and postoperative POP-Q values of the patients undergone Laparoscopic Sacrohysteropexy and Sacrocolpopexy SurgeriesWithout Using Mesh, Comparison of pre and postoperative PISQ-12 scores of the patients undergone Laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Without Using Mesh

06

What researchers measure

Primary outcomes

  1. Pre and post operative assessment of POP-Q measurements

    POP-Q values of patients before and after laparoscopic Sacrohysteropexy and Sacrocolpopexy Surgeries Performed Without Mesh on Pelvic Organ Prolapse will be compared.

    Time frame: 1 year

  2. Pre and post operative assessment of Pelvic Organ Prolapse / Incontinence Sexual

    Units on a scale of the patients obtained with Pelvic Organ Prolapse / Incontinence Sexual Questionnaire (PISQ-12) will be compared before and after surgery.

    Time frame: 1 year

07

Study locations

1 site
  • Gaziosmanpasa Training and Research Hospital
    Istanbul, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06176521
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Responsible party
Sponsor
First posted
Dec 19, 2023
Start date
Nov 1, 2023
Primary completion
Dec 1, 2024
Completion
Jun 1, 2025
Last update
Aug 6, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion